Sterling, Virginia-based biotech company Aperiomics has launched a new test that can detect COVID-19.
Founded in 2014, the company uses genomic analysis and machine learning to detect known pathogens from a sample of any nature in just one test. Aperiomics reports that its Xplore-PATHO tech can accurately identify nearly 40,000 microorganisms including over 12,000 clinically relevant pathogens.
Image: An Xplore-COVID-19 testing kit from Aperiomics - Courtesy Photo